| RCL |
ROYAL CARIBBEAN CRUISES LTD |
Holtz Naftali |
Officer
|
2026-02-12 |
F - D |
713 |
337.84 |
240,879.92 |
79,997 |
| NPO |
Enpro Inc. |
Humphrey John |
Director
|
2026-02-12 |
A - A |
567 |
246.91 |
139,997.97 |
4,429 |
| AVDL |
AVADEL PHARMACEUTICALS PLC |
Palczuk Linda |
Director
|
2026-02-12 |
D - D |
78,905 |
21.00 |
1,657,005.00 |
0 |
| AVDL |
AVADEL PHARMACEUTICALS PLC |
Palczuk Linda |
Director
|
2026-02-12 |
D - D |
60,000 |
0.00 |
0.00 |
0 |
| AVDL |
AVADEL PHARMACEUTICALS PLC |
Palczuk Linda |
Director
|
2026-02-12 |
D - D |
42,000 |
0.00 |
0.00 |
0 |
| AVDL |
AVADEL PHARMACEUTICALS PLC |
Palczuk Linda |
Director
|
2026-02-12 |
D - D |
42,000 |
0.00 |
0.00 |
0 |
| AVDL |
AVADEL PHARMACEUTICALS PLC |
Palczuk Linda |
Director
|
2026-02-12 |
D - D |
42,000 |
0.00 |
0.00 |
0 |
| AVDL |
AVADEL PHARMACEUTICALS PLC |
Palczuk Linda |
Director
|
2026-02-12 |
D - D |
33,000 |
0.00 |
0.00 |
0 |
| AVDL |
AVADEL PHARMACEUTICALS PLC |
Palczuk Linda |
Director
|
2026-02-12 |
D - D |
11,000 |
0.00 |
0.00 |
0 |
| AVDL |
AVADEL PHARMACEUTICALS PLC |
Palczuk Linda |
Director
|
2026-02-12 |
D - D |
25,000 |
0.00 |
0.00 |
0 |
| AVDL |
AVADEL PHARMACEUTICALS PLC |
Palczuk Linda |
Director
|
2026-02-12 |
D - D |
11,000 |
0.00 |
0.00 |
0 |
| PII |
Polaris Inc. |
Mack Robert Paul |
Officer
|
2026-02-12 |
S - D |
3,963 |
67.08 |
265,838.04 |
84,269 |
| PII |
Polaris Inc. |
Mack Robert Paul |
Officer
|
2026-02-12 |
S - D |
3,823 |
66.57 |
254,497.11 |
80,446 |
| PCAR |
PACCAR INC |
Poplawski Brice J |
Officer
|
2026-02-12 |
M - A |
2,200 |
71.95 |
158,290.00 |
3,103 |
| PCAR |
PACCAR INC |
Poplawski Brice J |
Officer
|
2026-02-12 |
S - D |
2,200 |
130.41 |
286,902.22 |
903 |
| PCAR |
PACCAR INC |
Poplawski Brice J |
Officer
|
2026-02-12 |
M - D |
2,200 |
130.41 |
286,902.22 |
1,970 |
| RCL |
ROYAL CARIBBEAN CRUISES LTD |
Pujol Henry L |
Officer
|
2026-02-12 |
F - D |
91 |
337.84 |
30,743.44 |
14,509 |
| KNSA |
Kiniksa Pharmaceuticals International, plc |
Quart Barry D |
|
2026-02-12 |
M - A |
2,690 |
15.47 |
41,614.30 |
15,236 |
| KNSA |
Kiniksa Pharmaceuticals International, plc |
Quart Barry D |
|
2026-02-12 |
S - D |
2,690 |
45.00 |
121,050.00 |
12,546 |
| KNSA |
Kiniksa Pharmaceuticals International, plc |
Quart Barry D |
|
2026-02-12 |
M - D |
2,690 |
0.00 |
0.00 |
0 |
| RYTM |
RHYTHM PHARMACEUTICALS, INC. |
Smith Hunter C |
Officer
|
2026-02-12 |
S - D |
292 |
96.26 |
28,108.71 |
119,766 |
| RYTM |
RHYTHM PHARMACEUTICALS, INC. |
Smith Hunter C |
Officer
|
2026-02-12 |
S - D |
400 |
97.67 |
39,068.52 |
119,366 |
| RYTM |
RHYTHM PHARMACEUTICALS, INC. |
Smith Hunter C |
Officer
|
2026-02-12 |
S - D |
800 |
98.99 |
79,192.48 |
118,566 |
| RYTM |
RHYTHM PHARMACEUTICALS, INC. |
Smith Hunter C |
Officer
|
2026-02-12 |
S - D |
100 |
100.10 |
10,010.00 |
118,466 |
| ICHR |
ICHOR HOLDINGS, LTD. |
ROHRS THOMAS M |
Director
|
2026-02-12 |
M - A |
53,908 |
22.56 |
1,216,164.48 |
106,932 |